Overexpression of SMYD2 contributes to malignant outcome in gastric cancer
S Komatsu, D Ichikawa, S Hirajima, H Nagata… - British journal of …, 2015 - nature.com
Background: SET and MYND domain-containing protein 2 (SMYD2) is a lysine
methyltransferase for histone H3, p53 and Rb and inhibits their transactivation activities. In …
methyltransferase for histone H3, p53 and Rb and inhibits their transactivation activities. In …
Ahr activation leads to attenuation of murine autoimmune hepatitis: single-cell rna-seq analysis reveals unique immune cell phenotypes and gene expression …
The aryl hydrocarbon receptor (AhR) is a ubiquitously expressed ligand-activated
transcription factor. While initially identified as an environmental sensor, this receptor has …
transcription factor. While initially identified as an environmental sensor, this receptor has …
SMYD2 is highly expressed in pediatric acute lymphoblastic leukemia and constitutes a bad prognostic factor
LHT Sakamoto, RV de Andrade, MSS Felipe… - Leukemia research, 2014 - Elsevier
Acute lymphoblastic leukemia (ALL) is the most common childhood malignancy. Although
several clinical characteristics can be associated with worse prognosis, more robust …
several clinical characteristics can be associated with worse prognosis, more robust …
Discovery and characterization of a highly potent and selective aminopyrazoline-based in vivo probe (BAY-598) for the protein lysine methyltransferase SMYD2
E Eggert, RC Hillig, S Koehr, D Stöckigt… - Journal of medicinal …, 2016 - ACS Publications
Protein lysine methyltransferases have recently emerged as a new target class for the
development of inhibitors that modulate gene transcription or signaling pathways. SET and …
development of inhibitors that modulate gene transcription or signaling pathways. SET and …
MTSS1: beyond the integration of actin and membrane dynamics
MTSS1 is a ubiquitously expressed intracellular protein known mainly for its involvement in
basic cellular processes, such as the regulation of actin organization and membrane …
basic cellular processes, such as the regulation of actin organization and membrane …
[HTML][HTML] HtrA1: Its future potential as a novel biomarker for cancer
E Altobelli, D Marzioni, A Lattanzi… - Oncology …, 2015 - spandidos-publications.com
HtrA1 appears to be involved in several physiological processes as well as in the
pathogenesis of conditions such as Alzheimer's disease and osteoarthritis. It has also been …
pathogenesis of conditions such as Alzheimer's disease and osteoarthritis. It has also been …
Discovery of substrates for a SET domain lysine methyltransferase predicted by multistate computational protein design
Characterization of lysine methylation has proven challenging despite its importance in
biological processes such as gene transcription, protein turnover, and cytoskeletal …
biological processes such as gene transcription, protein turnover, and cytoskeletal …
[HTML][HTML] Identification of a seven-gene prognostic signature using the gene expression profile of osteosarcoma
Z Liu, Y Zhong, S Meng, Q Liao… - Annals of Translational …, 2022 - ncbi.nlm.nih.gov
Background Osteosarcoma is a malignant bone tumor that typically occurs in adolescents or
children under 20 years of age. Develo** efficient clinical prognostic markers is crucial for …
children under 20 years of age. Develo** efficient clinical prognostic markers is crucial for …
Analysis of RPL37A, MTSS1, and HTRA1 expression as potential markers for pathologic complete response and survival
Background Non-metastatic locally advanced breast carcinoma (LABC) treatment involves
neoadjuvant chemotherapy (NCT). We evaluated the association of clinical–pathological …
neoadjuvant chemotherapy (NCT). We evaluated the association of clinical–pathological …
Identification of the antigens recognised by colorectal cancer patients using sera from patients who exhibit a Crohn's-like lymphoid reaction
VB Boncheva, M Linnebacher, S Kdimati, H Draper… - Biomolecules, 2022 - mdpi.com
A Crohn's-like lymphoid reaction (CLR) is observed in about 15% of colorectal cancer (CRC)
patients and is associated with favourable outcomes. To identify the immune targets …
patients and is associated with favourable outcomes. To identify the immune targets …